Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Elizabeth C S Swart"'
Autor:
Samuel K. Peasah, Elizabeth C. S. Swart, Yan Huang, Sandra L. Kane-Gill, Amy L. Seybert, Urvashi Patel, Chronis Manolis, Chester B. Good
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 2, Pp 241-249 (2024)
Abstract Background Disease-modifying anti-rheumatic drugs (DMARDs), since their introduction in 1990, have revolutionized the management of rheumatoid arthritis. Newer DMARDs have recently been approved, influencing treatment patterns and clinical g
Externí odkaz:
https://doaj.org/article/36c34275f52a496c8519d6bdc4ecb46b
Autor:
Jennifer L. Nguyen, Kiraat Munshi, Samuel K. Peasah, Elizabeth C. S. Swart, Monal Kohli, Rochelle Henderson, Chester B. Good
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Objective This study examines changes in utilization and costs trends associated with migraine medications. Background Migraine attacks are a burden to many patients. There are many pharmacotherapy options available with newer migraine drug
Externí odkaz:
https://doaj.org/article/87713e6cdce944219602ac8a7fa73067
Autor:
Lynn M. Neilson, Elizabeth C. S. Swart, Chester B. Good, William H. Shrank, Rochelle Henderson, Chronis Manolis, Natasha Parekh
Publikováno v:
Cardiology and Therapy, Vol 8, Iss 1, Pp 135-143 (2019)
Abstract Introduction Value-based contracts (VBCs) that link drug payments to disease-related performance metrics aim to increase the value and lower the cost of medications by aligning incentives and sharing risk between payers and pharmaceutical ma
Externí odkaz:
https://doaj.org/article/d3e3fe18de9140028597fda30256ad01
Identifying outcome measures for atrial fibrillation value-based contracting using the Delphi method
Autor:
Chester B. Good, Yan Huang, Rochelle Henderson, Lynn M Neilson, Elizabeth C S Swart, Utibe R. Essien, Chronis Manolis
Publikováno v:
Research in Social and Administrative Pharmacy. 18:3425-3431
Background Value-based contracts that tie payments for pharmaceuticals to predefined outcomes aim to promote value through shared risk and aligned incentives between manufacturers and payers. Methods We conducted a Delphi study among diverse stakehol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cecf027bc1b4c863765da2f5e177e0d
https://doi.org/10.1016/j.sapharm.2021.10.008
https://doi.org/10.1016/j.sapharm.2021.10.008
Autor:
Janel, Hanmer, Amy M, Cizik, Bernice G, Gulek, Polly, McCracken, Elizabeth C S, Swart, Rose, Turner, Suzanne M, Kinsky
Publikováno v:
The American Journal of Managed Care. 28:e232-e238
To complete a scoping review of US health insurers' use of health-related quality of life (HRQOL) patient-reported outcome measures (PROMs).Literature review.A literature search was constructed for articles that contained an insurer-related term and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8757cd75b425f6a55e8ffb350274641a
https://doi.org/10.37765/ajmc.2022.89162
https://doi.org/10.37765/ajmc.2022.89162
Autor:
Lynn M Neilson, Chronis Manolis, Kiraat D. Munshi, Chester B. Good, Samuel K Peasah, Elizabeth C S Swart, Yan Huang, Rochelle Henderson
Publikováno v:
Medical Care. 59:789-794
OBJECTIVE The objective of this study was to describe national changes in utilization and associated costs of antidiabetic medications in the United States from 2014 to 2019, across different drug classes and insurance plans. RESEARCH DESIGN AND METH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eb5e7207fa21b6208919ea49b76d98b
https://doi.org/10.1097/mlr.0000000000001597
https://doi.org/10.1097/mlr.0000000000001597
Autor:
Kiraat D. Munshi, Chester B. Good, Terri V Newman, Lynn M Neilson, Yan Huang, Rochelle Henderson, Elizabeth C S Swart, Natasha Parekh
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 27:435-443
BACKGROUND: Because of improved clinical outcomes, recent American Diabetes Association guidelines recommend the use of newer antidiabetic agents-glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13505c6f240ad90da84e8b9a47ba0600
https://doi.org/10.18553/jmcp.2021.27.4.435
https://doi.org/10.18553/jmcp.2021.27.4.435
Autor:
Elizabeth C S Swart, Chester B. Good, Yan Huang, Rochelle Henderson, Lynn M Neilson, Caroline Swift, Kiraat D. Munshi, Natasha Parekh
Publikováno v:
J Gen Intern Med
BACKGROUND: Given efforts to reduce opioid use, and because marijuana potentially offers a lower-risk alternative for treating chronic pain, there is interest in understanding the public health impact of marijuana legalization on opioid-related outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2540e793f454903aa74f12072f43e58
https://doi.org/10.1007/s11606-020-06530-6
https://doi.org/10.1007/s11606-020-06530-6
Autor:
Kiraat D. Munshi, Lynn M Neilson, Mark Mueller, SamuelK. Peasah, Chronis Manolis, Rochelle Henderson, Monal Kohli, Elizabeth C S Swart, Chester B. Good, Yan Huang
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 5, Iss, Pp 100094-(2022)
Recent studies have suggested that extended duration oral contraceptive pills (OCP), such as the 12-month duration, have a positive impact on pregnancy rates but negative impact on pill wastage. Several states have since been mandating health plans t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b157c7acdca27b595725fec8f06abde
http://www.sciencedirect.com/science/article/pii/S2667276621000949
http://www.sciencedirect.com/science/article/pii/S2667276621000949
Autor:
Lynn M Neilson, Elizabeth C S Swart, Chronis Manolis, Natasha Parekh, Chester B. Good, Jessica Daw
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 26:1385-1389
In an effort to demonstrate measurable value of pharmaceuticals in the United States, many payers and drug manufacturers have entered into value-based purchasing contracts that link payment for prescription medications to patient outcomes, creating s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f32c7771ff6a597cbb674a518672174
https://doi.org/10.18553/jmcp.2020.26.11.1385
https://doi.org/10.18553/jmcp.2020.26.11.1385